2006
DOI: 10.1016/j.jvs.2006.06.021
|View full text |Cite
|
Sign up to set email alerts
|

Agenesis of the inferior vena cava associated with lower extremities and pelvic venous thrombosis

Abstract: The absence of the inferior vena cava is an uncommon congenital anomaly and can be misdiagnosed. We report a 14-year-old boy initially admitted as a result of a painful abdominal mass; after admission, he experienced a deep venous thrombosis in his left leg. Subsequent evaluation revealed the congenital absence of the entire inferior vena cava, with a cluster of thrombosed collateral veins in his right pelvis, corresponding to the abdominal mass. The recognition of this anomaly may be helpful in the event of d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
55
0
1

Year Published

2007
2007
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(56 citation statements)
references
References 20 publications
0
55
0
1
Order By: Relevance
“…There are some reports of recurrence of thrombosis after discontinuation of the treatment [12]. The treatment was conducted according with clinical evolution and serial ultrasound aspects.…”
Section: Discussionmentioning
confidence: 99%
“…There are some reports of recurrence of thrombosis after discontinuation of the treatment [12]. The treatment was conducted according with clinical evolution and serial ultrasound aspects.…”
Section: Discussionmentioning
confidence: 99%
“…12) In most of the DVT cases with IVC anomaly, conventional anticoagulation therapy with warfarin has been used to relieve the symptoms. 6,[13][14][15] As the patients who experienced thrombosis due to IVC anomaly may have a higher risk for thrombotic recurrence, lifelong anticoagulation therapy should be considered. 15,16) Recently, direct oral anticoagulants (DOACs) have been developed as alternatives to the conventional therapy with warfarin for the treatment of acute venous thromboembolism events.…”
Section: Discussionmentioning
confidence: 99%
“…6,[13][14][15] As the patients who experienced thrombosis due to IVC anomaly may have a higher risk for thrombotic recurrence, lifelong anticoagulation therapy should be considered. 15,16) Recently, direct oral anticoagulants (DOACs) have been developed as alternatives to the conventional therapy with warfarin for the treatment of acute venous thromboembolism events. [17][18][19][20][21][22][23] Nevertheless, the clinical efficiency for DOACs for patients with IVC anomalies remains unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Other congenital problems are rarer still, but agenesis of vessels (such as the inferior vena cava 13 ) form a significant proportion of these, and can manifest themselves as other disease states such as venous thromboembolic (VTE) disease.…”
Section: Congenital Venous Diseasesmentioning
confidence: 99%